Foravirumab
Foravirumab is an experimental monoclonal antibody designed for the treatment of HIV infection. It was developed by Progenics Pharmaceuticals and is currently in the preclinical stage of development.
Mechanism of Action[edit]
Foravirumab works by binding to the gp120 protein on the surface of the HIV virus. This prevents the virus from attaching to and entering human cells, thereby stopping the spread of the infection.
Development and Clinical Trials[edit]
Foravirumab is currently in the preclinical stage of development. This means that it has not yet been tested in humans. The safety and efficacy of foravirumab are currently being evaluated in laboratory and animal studies.
Potential Advantages[edit]
Foravirumab has the potential to offer several advantages over existing HIV treatments. It is a monoclonal antibody, which means it is highly specific for its target and is less likely to cause side effects. Additionally, foravirumab could potentially be used in combination with other HIV treatments to increase their effectiveness.
Potential Disadvantages[edit]
As foravirumab is still in the preclinical stage of development, its potential disadvantages are not yet known. However, like all drugs, it may have side effects and may not work for everyone.
See Also[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
